CBUS vs CTVA
CBUS: Cibus is an agricultural biotechnology company that uses precision gene editing to help seed companies create higher-yielding, more resilient crops faster than traditional breeding. CTVA: Corteva is a global agriculture leader specializing in advanced seed technology and crop protection solutions to support sustainable farming.
Side-by-side fundamentals
| Metric | CBUS | CTVA | Edge |
|---|---|---|---|
| Price as of 2026-10-20 close | $1.39 | $12.90 | |
| Market cap | $106M | $8.6B | |
| P/E as of 2026-10-20 | n/a | 8.43 | |
| PEG as of 2026-10-20, 3-year EPS CAGR to FY2025 | n/a | 20.07 | |
| Net margin FY2025, SEC XBRL | -3492.3% | +6.3% | CTVA higher |
| Gross margin FY2022, SEC XBRL | +100.0% | n/a | |
| Operating margin FY2025, SEC XBRL | -2680.1% | n/a | |
| ROE FY2025, SEC XBRL | -582.2% | +4.5% | CTVA higher |
| ROA FY2025, SEC XBRL | -41.7% | +2.6% | CTVA higher |
| Debt / equity | 0.06 | 0.07 | CBUS lower |
| Revenue growth (YoY) FY2025, SEC XBRL | -14.6% | +2.9% | CTVA higher |
| Revenue CAGR (3y) SEC XBRL | +185.1% | -0.1% | CBUS higher |
| Dividend yield as of 2026-09-03 | n/a | +0.9% | |
| Dividend streak (yrs) SEC XBRL | 0 | 7 | CTVA higher |
| Beta as of 2026-09-03 | 1.81 | 0.50 | |
| 1-year return as of 2026-10-20 close | -16.3% | n/a |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.